Today: 22 April 2026
IREN Stock Price Slips as $6 Billion Share-Sale Plan Tests AI Buildout
13 March 2026
2 mins read

IREN Stock Price Slips as $6 Billion Share-Sale Plan Tests AI Buildout

NEW YORK, March 12, 2026, 6:15 PM EDT

IREN slipped roughly 1.3% to $41.37 on Thursday, surrendering some of Wednesday’s sharp 10% rally. Pressure from a broader pullback in U.S. growth stocks weighed on the shares. The Nasdaq Composite lost 1.78%, with traders on edge over rallying oil prices and heightened Middle East tensions.

This is significant: IREN is deep into a pricey transition, moving out of bitcoin mining and into AI cloud services. Back on March 4, it announced plans to pick up more than 50,000 Nvidia B300 GPUs—the same chips powering today’s AI models. The company also boosted its at-the-market stock-sale program, giving it the option to issue fresh shares gradually.

IREN expects its expanded hardware to push the total GPU count to 150,000, a boost that, by the end of 2026, could drive more than $3.7 billion in AI-cloud annualized run-rate revenue—a ballpark figure for potential yearly sales at that scale. “Scaling to 150,000 GPUs positions IREN among the largest AI cloud infrastructure providers globally,” co-CEO Daniel Roberts said. Nasdaq

Financing remains the sticking point for many investors. According to a March 4 SEC filing, IREN now has authorization to sell as much as $6 billion in ordinary shares—this comes after tapping out a previous $1 billion facility, with 66.7 million shares already sold for roughly $1 billion. The prospectus flagged the risk: additional share sales could dilute existing holdings, cutting investors’ stakes and potentially weighing on the stock.

IREN described the equity program as an addition to its existing funding mix as the company ramps up. In its March 4 statement, the firm said it had lined up $9.3 billion in funding over the past eight months. Management is planning for another $3.5 billion in capital outlays for new GPU orders, set for the back half of 2026.

Even so, the most recent quarter lays bare the market’s skepticism. For the three months ending Dec. 31, total revenue dropped 23.1% sequentially to $184.7 million. IREN booked a net loss of $155.4 million. Bitcoin mining brought in $167.4 million in sales; AI cloud services contributed just $17.3 million.

Management insists demand isn’t the issue. Back in February, Roberts described IREN’s situation as “the strongest demand environment to date,” highlighting over 4.5 gigawatts of locked-in power for the next stage of expansion. Nasdaq

There’s at least one big-name client. Back in November, Reuters reported that Microsoft lined up a $9.7 billion, five-year deal with IREN for Nvidia-powered cloud resources—a contract that quickly shifted investor perception, pushing the company squarely into the AI infrastructure spotlight.

IREN wasn’t alone in Thursday’s slide. Shares in Applied Digital ended down around 3.7%, Cipher Digital lost close to 2.8%, and Core Scientific shed 1.8%. The moves point to broader selling pressure in riskier tech stocks as investors trimmed positions.

Still, hitting that upside depends on how well IREN delivers. The company puts its $3.7 billion AI revenue projection down to internal modeling, not solid contracts, while Cantor Fitzgerald’s Brett Knoblauch flagged investor worry about “capex, financing cost, and ultimately returns” in his February note. Right now, the shares are caught—caught between bets on massive growth and nagging questions about just how much cash and fresh equity will be needed to pull it off. Nasdaq

Stock Market Today

  • BioMarin Pharmaceutical Seen as Undervalued After Years of Share Price Declines
    April 22, 2026, 10:25 AM EDT. BioMarin Pharmaceutical's stock has underperformed with an 8.1% year-to-date decline and a 42.8% drop over three years. Despite this, a Discounted Cash Flow (DCF) model values the stock at about $190.15 per share, suggesting it is 71.3% undervalued compared to the recent price of $54.62. The model forecasts free cash flow growth to $1.6 billion by 2035, indicating potential upside. However, the stock scores only 2 out of 6 in valuation checks, reflecting caution among investors. These mixed signals prompt debate on whether the current price fully reflects past setbacks or if value remains. Investors should weigh BioMarin's long-term cash flow prospects against ongoing risks and recent performance trends before deciding.

Latest article

Boeing Q1 2026 Earnings Beat as 143 Jet Deliveries Cut Losses, but Cash Burn Still Weighs

Boeing Q1 2026 Earnings Beat as 143 Jet Deliveries Cut Losses, but Cash Burn Still Weighs

22 April 2026
Boeing posted a first-quarter net loss of $7 million, far smaller than analysts’ forecasts, as revenue rose 14% to $22.2 billion on stronger jet deliveries. Free cash flow remained negative at $1.5 billion, but improved from last year. Commercial airplanes delivered 143 jets, outpacing Airbus, but the unit still lost $563 million. Total backlog reached a record $695 billion, with defense and services offsetting some losses.
Why Strategy Stock (MSTR) Is Outpacing Bitcoin Again After a $2.54 Billion Buy

Why Strategy Stock (MSTR) Is Outpacing Bitcoin Again After a $2.54 Billion Buy

22 April 2026
Strategy, formerly MicroStrategy, bought 34,164 bitcoin for $2.54 billion in the week ended April 19, raising its total to 815,061 coins. The company funded the purchase by selling $2.54 billion in securities, including 21.8 million STRC preferred shares. Strategy’s latest acquisition puts its bitcoin holdings ahead of BlackRock’s IBIT. Shares were down 4% premarket Wednesday but had risen nearly 37% in April.
Axe Compute (AGPU) stock in focus after biggest-ever $260 million Nvidia B300 contract

Axe Compute (AGPU) stock in focus after biggest-ever $260 million Nvidia B300 contract

22 April 2026
Axe Compute announced a $260 million, 36-month contract to supply 2,304 Nvidia B300 GPUs and high-speed storage to an undisclosed enterprise customer, with deployment set for Q3 2026 at a U.S. Tier 3 data center. The company reported only $125,284 in 2025 revenue, all from its legacy business, and has not yet recognized any revenue from AI infrastructure.
Mosaic stock jumps 7% as Hormuz supply shock lifts fertilizer prices
Previous Story

Mosaic stock jumps 7% as Hormuz supply shock lifts fertilizer prices

Northern Star Resources Ltd share price in focus after fresh FY26 gold output warning
Next Story

Northern Star Resources Ltd share price in focus after fresh FY26 gold output warning

Go toTop